Cerilliant Corporation

Total Page:16

File Type:pdf, Size:1020Kb

Cerilliant Corporation Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices 21999 Drug Schedule Drug Schedule Administration, that the requirements for such registration pursuant to 21 Etorphine HCl (9059) ................... I Hydromorphone (9150) ................ II U.S.C. 958(a); 21 U.S.C. 823(a); and 21 Codeine methylbromide (9070) .... I Diphenoxylate (9170) ................... II CFR 1301.34(b), (c), (d), (e), and (f) are Dihydromorphine (9145) ............... I Benzoylecgonine (9180) ............... II satisfied. Difenoxin (9168) ........................... I Ethylmorphine (9190) ................... II Heroin (9200) ............................... I Hydrocodone (9193) ..................... II Dated: April 2, 2012. Hydromorphinol (9301) ................. I Levomethorphan (9210) ............... II Joseph T. Rannazzisi, Methyldesorphine (9302) .............. I Levorphanol (9220) ...................... II Deputy Assistant Administrator, Office of Methyldihydromorphine (9304) ..... I Isomethadone (9226) ................... II Diversion Control, Drug Enforcement Morphine methylbromide (9305) .. I Meperidine (9230) ........................ II Administration. Morphine methylsulfonate (9306) I Meperidine intermediate-B (9233) II Morphine-N-oxide (9307) ............. I Metazocine (9240) ........................ II [FR Doc. 2012–8763 Filed 4–11–12; 8:45 am] Myrophine (9308) ......................... I Methadone (9250) ........................ II BILLING CODE 4410–09–P Nicocodeine (9309) ...................... I Methadone intermediate (9254) ... II Nicomorphine (9312) .................... I Metopon (9260) ............................ II Normorphine (9313) ..................... I Dextropropoxyphene, bulk (non- II DEPARTMENT OF JUSTICE Pholcodine (9314) ........................ I dosage forms) (9273). Acetorphine (9319) ....................... I Morphine (9300) ........................... II Drug Enforcement Administration Acetylmethadol (9601) ................. I Thebaine (9333) ........................... II Allylprodine (9602) ....................... I Dihydroetorphine (9334) ............... II Importer of Controlled Substances; Alphacetylmethadol except levo- I Levo-alphacetylmethadol (9648) .. II Notice Of Registration; Cerilliant alphacetyl-methadol (9603). Oxymorphone (9652) ................... II Corporation Alphamethadol (9605) .................. I Noroxymorphone (9668) .............. II Dioxaphetyl butyrate (9621) ......... I Phenazocine (9715) ..................... II By Notice dated January 6, 2012, and Dipipanone (9622) ........................ I Piminodine (9730) ........................ II published in the Federal Register on Ethylmethylthiambutene (9623) .... I Racemethorphan (9732) .............. II January 17, 2012, 77 FR 2321, Cerilliant Etonitazene (9624) ....................... I Racemorphan (9733) ................... II Corporation, 811 Paloma Drive, Suite A, Etoxeridine (9625) ........................ I Alfentanil (9737) ........................... II Round Rock, Texas 78665–2402, made Furethidine (9626) ........................ I Remifentanil (9739) ...................... II application by renewal to the Drug Hydroxypethidine (9627) .............. I Sufentanil (9740) .......................... II Ketobemidone (9628) ................... I Carfentanil (9743) ......................... II Enforcement Administration (DEA) to Levomoramide (9629) .................. I Tapentadol (9780) ........................ II be registered as an importer of the Levophenacylmorphan (9631) ...... I Bezitramide (9800) ....................... II following basic classes of controlled Morpheridine (9632) ..................... I Fentanyl (9801) ............................ II substances: Noracymethadol (9633) ................ I Norlevorphanol (9634) .................. I The company plans to import Drug Schedule Normethadone (9635) .................. I analytical reference standards for Norpipanone (9636) ..................... I distribution to its customers for research Cathinone (1235) .......................... I Phenadoxone (9637) .................... I Methcathinone (1237) .................. I Phenampromide (9638) ................ I and analytical purposes. N-Ethylamphetamine (1475) ........ I Phenoperidine (9641) ................... I Any bulk manufacturer who is N,N-Dimethylamphetamine (1480) I Piritramide (9642) ......................... I presently, or is applying to be, Fenethylline (1503) ....................... I Proheptazine (9643) ..................... I registered with DEA to manufacture Gamma Hydroxybutyric Acid I Properidine (9644) ........................ I such basic classes of controlled (2010). Racemoramide (9645) .................. I substances may file comments or Alpha-ethyltryptamine (7249) ....... I Trimeperidine (9646) .................... I objections to the issuance of the Ibogaine (7260) ............................ I Phenomorphan (9647) ................. I proposed registration, and may, at the Lysergic acid diethylamide (7315) I Levo-alphacetylmethadol (9648) .. I same time, file a written request for a Drug Schedule. Propiram (9649) ........................... I 2,5-Dimethoxy-4-(n)- I Tilidine (9750) ............................... I hearing on such application pursuant to propylthiophenethylamine Para-Fluorofentanyl (9812) .......... I 21 CFR 1301.43, and in such form as (7348). 3–Methylfentanyl (9813) ............... I prescribed by 21 CFR 1316.47. Marihuana (7360) ......................... I Acetyl-alpha-methylfentanyl I Any such comments or objections Tetrahydrocannabinols (7370) ..... I (9815). should be addressed, in quintuplicate, Mescaline (7381) .......................... I Amphetamine (1100) .................... II to the Drug Enforcement 3,4,5-Trimethoxyamphetamine I Methamphetamine (1105) ............ II Administration, Office of Diversion (7390). Lisdexamfetamine (1205) ............. II Control, Federal Register Representative 4-Bromo-2,5- I Phenmetrazine (1631) .................. II (ODL), 8701 Morrissette Drive, dimethoxyamphetamine (7391). Methylphenidate (1724) ................ II 4-Bromo-2,5- I Amobarbital (2125) ....................... II Springfield, Virginia 22152; and must be dimethoxyphenethylamine Pentobarbital (2270) ..................... II filed no later than May 14, 2012. (7392). Secobarbital (2315) ...................... II This procedure is to be conducted 4-Methyl-2,5- I Glutethimide (2550) ...................... II simultaneously with, and independent dimethoxyamphetamine (7395). Nabilone (7379) ............................ II of, the procedures described in 21 CFR 2,5-Dimethoxyamphetamine I 1–Phenylcyclohexylamine (7460) II 1301.34(b), (c), (d), (e), and (f). As noted (7396). Phencyclidine (7471) .................... II in a previous notice published in the 3,4-Methylenedioxyamphetamine I 4–Anilino-N-phenethyl-4-piper- II Federal Register on September 23, 1975, (7400). idine (8333). 40 FR 43745–46, all applicants for 3,4-Methylenedioxy-N- I Phenylacetone (8501) .................. II registration to import a basic class of ethylamphetamine (7404). Alphaprodine (9010) ..................... II 3,4- I Anileridine (9020) ......................... II any controlled substance in schedule I Methylenedioxymethamphetam- Cocaine (9041) ............................. II or II are, and will continue to be, ine (7405). Codeine (9050) ............................. II required to demonstrate to the Deputy 4-Methoxyamphetamine (7411) ... I Dihydrocodeine (9120) ................. II Assistant Administrator, Office of 5-Methoxy-N-N- I Oxycodone (9143) ........................ II Diversion Control, Drug Enforcement dimethyltryptamine (7431). VerDate Mar<15>2010 16:27 Apr 11, 2012 Jkt 226001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\12APN1.SGM 12APN1 mstockstill on DSK4VPTVN1PROD with NOTICES 22000 Federal Register / Vol. 77, No. 71 / Thursday, April 12, 2012 / Notices Drug Schedule Cerilliant Corporation to ensure that the FOR FURTHER INFORMATION CONTACT: Will company’s registration is consistent Bronson, Designated Federal Official Alpha-methyltryptamine (7432) .... I with the public interest. The (DFO), Deputy Associate Administrator, Diethyltryptamine (7434) .............. I investigation has included inspection Child Protection Division, Office of Dimethyltryptamine (7435) ........... I and testing of the company’s physical Juvenile Justice & Delinquency Psilocybin (7437) .......................... I security systems, verification of the Psilocyn (7438) ............................. I Prevention, Office of Justice Programs, 5-Methoxy-N,N- I company’s compliance with state and 810 7th Street NW., Washington, DC diisopropyltryptamine (7439). local laws, and a review of the 20531. Phone: (202) 305–2427 [note: N-Benzylpiperazine (7493) ........... I company’s background and history. this is not a toll-free number]; email: Etorphine (except HCl) (9056) ..... I Therefore, pursuant to 21 U.S.C. 952(a) [email protected]. Heroin (9200) ............................... I and 958(a), and in accordance with 21 Morphine-N-oxide (9307) ............. I CFR 1301.34, the above named company SUPPLEMENTARY INFORMATION: This Normorphine (9313) ..................... I is granted registration as an importer of hearing is being convened to brief the Pholcodine (9314) ........................ I the basic classes of controlled task force members about the issue of Dextromoramide (9613) ............... I children’s exposure to violence. The Dipipanone (9622) ........................ I substances listed.
Recommended publications
  • Minnesota Statutes 1979 Supplement
    MINNESOTA STATUTES 1979 SUPPLEMENT 152.01 PROHIBITED DRUGS CHAPTER 152. PROHIBITED DRUGS Sec. 152.01 Definitions. 152.02 Schedules of controlled substances; admin­ istration of chapter. 152.01 Definitions. [For text of subds 1 to 8, see M.S.1978] Subd. 9. Marijuana. "Marijuana" means all parts of the plant of any species of the genus Cannabis, including all agronomical varieties, whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin, but shall not include the mature stalks of such plant, fiber from such stalks, oil or cake made from the seeds of such plant, any other compound, manufacture, salt, derivative, mix­ ture, or preparation of such mature stalks, except the resin extracted therefrom, fiber, oil, or cake, or the sterilized seed of such plant which is incapable of germination. [For text of subds 10 to 17, see M.S.1978] [ 1979 c 157 s 1 ] 152.02 Schedules of controlled substances; administration of chapter. [For text of subd 1, see M.S.1978) Subd. 2. The following items are listed in Schedule I: (1) Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the exis­ tence of such isomers, esters, ethers and salts is possible within the specific chemical des­ ignation: Acetylmethadol; Allylprodine; Alphacetylmethadol; Alphameprodine; Alpham- ethadol; Benzethidine; Betacetylmethadol; Betameprodine; Betamethadol; Betaprodine; Clonitazene; Dextromoramide; Dextrorphan; Diampromide; Diethyliambutene; Dime- noxadol; Dimepheptanol; Dimethyliambutene; Dioxaphetyl butyrate; Dipipanone; Ethylmethylthiambutene; Etonitazene; Etoxeridine; Furethidine; Hydroxypethidine; Ke- tobemidone; Levomoramide; Levophenacylmorphan; Morpheridine; Noracymethadol; Norlevorphanol; Normethadone; Norpipanone; Phenadoxone; Phenampromide; Pheno- morphan; Phenoperidine; Piritramide; Proheptazine; Properidine; Racemoramide; Tri­ meperidine.
    [Show full text]
  • 2020 Kansas Statutes
    2020 Kansas Statutes 65-4105. Substances included in schedule I. (a) The controlled substances listed in this section are included in schedule I and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it. (b) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N- phenylacetamide) 9821 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N- phenylacetamide) 9815 (3) Acetylmethadol 9601 (4) Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide; acryloylfentanyl) 9811 (5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide) 9551 (6) Allylprodine 9602 (7) Alphacetylmethadol 9603(except levo-alphacetylmethadol also known as levo- alpha-acetylmethadol, levomethadyl acetate or LAAM) (8) Alphameprodine 9604 (9) Alphamethadol 9605 (10) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine) 9814 (11) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N- phenylpropanamide) 9832 (12) Benzethidine 9606 (13) Betacetylmethadol 9607 (14) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N- phenylpropanamide) 9830 (15) Beta-hydroxy-3-methylfentanyl (other
    [Show full text]
  • SENATE BILL No. 52
    As Amended by Senate Committee Session of 2017 SENATE BILL No. 52 By Committee on Public Health and Welfare 1-20 1 AN ACT concerning the uniform controlled substances act; relating to 2 substances included in schedules I, II and V; amending K.S.A. 2016 3 Supp. 65-4105, 65-4107 and 65-4113 and repealing the existing 4 sections. 5 6 Be it enacted by the Legislature of the State of Kansas: 7 Section 1. K.S.A. 2016 Supp. 65-4105 is hereby amended to read as 8 follows: 65-4105. (a) The controlled substances listed in this section are 9 included in schedule I and the number set forth opposite each drug or 10 substance is the DEA controlled substances code which has been assigned 11 to it. 12 (b) Any of the following opiates, including their isomers, esters, 13 ethers, salts, and salts of isomers, esters and ethers, unless specifically 14 excepted, whenever the existence of these isomers, esters, ethers and salts 15 is possible within the specific chemical designation: 16 (1) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)- 17 N-phenylacetamide)......................................................................9821 18 (2) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4- 19 piperidinyl]-N-phenylacetamide)..................................................9815 20 (3) Acetylmethadol.............................................................................9601 21 (4) AH-7921 (3.4-dichloro-N-[(1- 22 dimethylaminocyclohexylmethyl]benzamide)...............................9551 23 (4)(5) Allylprodine...........................................................................9602
    [Show full text]
  • Federal Register/Vol. 85, No. 178/Monday, September 14, 2020
    Federal Register / Vol. 85, No. 178 / Monday, September 14, 2020 / Notices 56631 agreements. All non-confidential DEPARTMENT OF JUSTICE ADDRESSES: Written comments should written submissions will be available for be sent to: Drug Enforcement public inspection at the Office of the Drug Enforcement Administration Administration, Attention: DEA Federal Secretary and on EDIS. [Docket No. DEA–713] Register Representative/DPW, 8701 The Commission vote for these Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must determinations took place on September Importer of Controlled Substances Application: Cerilliant Corporation be sent to: Drug Enforcement 8, 2020. Administration, Attn: Administrator, The authority for the Commission’s AGENCY: Drug Enforcement 8701 Morrissette Drive, Springfield, determination is contained in section Administration, Justice. Virginia 22152. All request for a hearing 337 of the Tariff Act of 1930, as ACTION: Notice of application. should also be sent to: (1) Drug amended (19 U.S.C. 1337), and in Part SUMMARY: Cerilliant Corporation has Enforcement Administration, Attn: 210 of the Commission’s Rules of applied to be registered as an importer Hearing Clerk/OALJ, 8701 Morrissette Practice and Procedure (19 CFR part of basic class(es) of controlled Drive, Springfield, Virginia 22152; and 210). substance(s). Refer to Supplemental (2) Drug Enforcement Administration, Attn: DEA Federal Register By order of the Commission. Information listed below for further Representative/DPW, 8701 Morrissette Issued: September 8, 2020. drug information. DATES: Drive, Springfield, Virginia 22152. Lisa Barton, Registered bulk manufacturers of the affected basic class(es), and SUPPLEMENTARY INFORMATION: In Secretary to the Commission. applicants therefore, may file written accordance with 21 CFR 1301.34(a), this [FR Doc.
    [Show full text]
  • CONTROLLED SUBSTANCE, DRUG, DEVICE and COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun
    CONTROLLED SUBSTANCE, DRUG, DEVICE AND COSMETIC ACT - SCHEDULE I CONTROLLED SUBSTANCES Act of Jun. 23, 2011, P.L. 36, No. 7 Cl. 35 Session of 2011 No. 2011-7 SB 1006 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for Schedule I controlled substances. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 4(1) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, amended November 24, 1999 (P.L.894, No.55), is amended to read: Section 4. Schedules of Controlled Substances.--The following schedules include the controlled substances listed or to be listed by whatever official name, common or usual name, chemical name, or trade name designated. (1) Schedule I--In determining that a substance comes within this schedule, the secretary shall find: a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. The following controlled substances are included in this schedule: (i) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: 1.
    [Show full text]
  • Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017
    Q UO N T FA R U T A F E BERMUDA PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 BR 111 / 2017 The Minister responsible for health, in exercise of the power conferred by section 48A(1) of the Pharmacy and Poisons Act 1979, makes the following Order: Citation 1 This Order may be cited as the Pharmacy and Poisons (Third and Fourth Schedule Amendment) Order 2017. Repeals and replaces the Third and Fourth Schedule of the Pharmacy and Poisons Act 1979 2 The Third and Fourth Schedules to the Pharmacy and Poisons Act 1979 are repealed and replaced with— “THIRD SCHEDULE (Sections 25(6); 27(1))) DRUGS OBTAINABLE ONLY ON PRESCRIPTION EXCEPT WHERE SPECIFIED IN THE FOURTH SCHEDULE (PART I AND PART II) Note: The following annotations used in this Schedule have the following meanings: md (maximum dose) i.e. the maximum quantity of the substance contained in the amount of a medicinal product which is recommended to be taken or administered at any one time. 1 PHARMACY AND POISONS (THIRD AND FOURTH SCHEDULE AMENDMENT) ORDER 2017 mdd (maximum daily dose) i.e. the maximum quantity of the substance that is contained in the amount of a medicinal product which is recommended to be taken or administered in any period of 24 hours. mg milligram ms (maximum strength) i.e. either or, if so specified, both of the following: (a) the maximum quantity of the substance by weight or volume that is contained in the dosage unit of a medicinal product; or (b) the maximum percentage of the substance contained in a medicinal product calculated in terms of w/w, w/v, v/w, or v/v, as appropriate.
    [Show full text]
  • A45 14-Methoxy-Metopon: a Highly Potent Μ Opioid Agonist on Rat Vas
    APHAR 2007 Abstract Preview A45 14-Methoxy-metopon: a highly potent µ opioid agonist on rat vas deferens Kornél P Király1, Pál Riba1, Tamás Friedmann1, Mahmoud Al-Khrasani1, Helmut Schmidhammer2 and Susanna Fürst1 1Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary 2Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Austria E-Mail: [email protected] Morphine, the opioid analgesic most abundantly used for severe acute and chronic pain, is associated with several adverse effects such as respiratory depression, tolerance and dependence. The intensive search to find new opioids possessing a better pharmacological profile has resulted in 14-O-methyloxymorphone (14-O-MOX) and 14-methoxy- metopon (MET), a highly µ-selective and very potent opioid agonist. Our aim was to test the compounds in the rat vas deferens (RVD) bioassay system in order to further analyze their µ receptor efficacy and elucidate the structure-activity relationship between the compounds and oxymorphone (OX), their parent molecule. RVD was prepared, mounted and stimulated as described by Ronai et al. [1]. Opioid actions were measured by determining the inhibitory effects on the electrically evoked twitches. Antagonist activity was determined by the single-dose method. MET exerted full agonist activity in RVD, unlike OX and 14-O-MOX which were only partial agonists. Naltrexone, the reference µ receptor antagonist, antagonized the inhibitory actions on the electrically evoked twitches of the test compounds with a similar potency than in mouse vas deferens indicating the presence of µ opioid receptors in RVD. We found that MET is a highly efficacious µ receptor agonist and that the 5-methyl substitution may be responsible for the full agonist activity.
    [Show full text]
  • Drugs of Abuseon September Archived 13-10048 No
    U.S. DEPARTMENT OF JUSTICE DRUG ENFORCEMENT ADMINISTRATION WWW.DEA.GOV 9, 2014 on September archived 13-10048 No. v. Stewart, in U.S. cited Drugs of2011 Abuse EDITION A DEA RESOURCE GUIDE V. Narcotics WHAT ARE NARCOTICS? Also known as “opioids,” the term "narcotic" comes from the Greek word for “stupor” and originally referred to a variety of substances that dulled the senses and relieved pain. Though some people still refer to all drugs as “narcot- ics,” today “narcotic” refers to opium, opium derivatives, and their semi-synthetic substitutes. A more current term for these drugs, with less uncertainty regarding its meaning, is “opioid.” Examples include the illicit drug heroin and pharmaceutical drugs like OxyContin®, Vicodin®, codeine, morphine, methadone and fentanyl. WHAT IS THEIR ORIGIN? The poppy papaver somniferum is the source for all natural opioids, whereas synthetic opioids are made entirely in a lab and include meperidine, fentanyl, and methadone. Semi-synthetic opioids are synthesized from naturally occurring opium products, such as morphine and codeine, and include heroin, oxycodone, hydrocodone, and hydromorphone. Teens can obtain narcotics from friends, family members, medicine cabinets, pharmacies, nursing 2014 homes, hospitals, hospices, doctors, and the Internet. 9, on September archived 13-10048 No. v. Stewart, in U.S. cited What are common street names? Street names for various narcotics/opioids include: ➔ Hillbilly Heroin, Lean or Purple Drank, OC, Ox, Oxy, Oxycotton, Sippin Syrup What are their forms? Narcotics/opioids come in various forms including: ➔ T ablets, capsules, skin patches, powder, chunks in varying colors (from white to shades of brown and black), liquid form for oral use and injection, syrups, suppositories, lollipops How are they abused? ➔ Narcotics/opioids can be swallowed, smoked, sniffed, or injected.
    [Show full text]
  • SB566 1 119787-1 2 by Senators Orr, Erwin, Sanford, and Butler 3 RFD
    1 SB566 2 119787-1 3 By Senators Orr, Erwin, Sanford, and Butler 4 RFD: Judiciary 5 First Read: 23-MAR-10 Page 0 1 119787-1:n:03/08/2010:DA/mfp LRS2010-1714 2 3 4 5 6 7 8 SYNOPSIS: Under existing law, salvia divinorum and 9 Salvinorin A are not listed as controlled 10 substances. 11 This bill would list salvia divinorum and 12 Salvinorin A as Schedule I controlled substances. 13 14 A BILL 15 TO BE ENTITLED 16 AN ACT 17 18 To amend Section 20-2-23 of the Code of Alabama 19 1975, relating to Schedule I controlled substances, to list 20 salvia divinorum and Salvinorin A. 21 BE IT ENACTED BY THE LEGISLATURE OF ALABAMA: 22 Section 1. Section 20-2-23 of the Code of Alabama 23 1975, is amended to read as follows: 24 "§20-2-23. 25 "The controlled substances listed in this section 26 are included in Schedule I: Page 1 1 "(1) Any of the following opiates, including their 2 isomers, esters, ethers, salts, and salts of isomers, esters 3 and ethers, unless specifically excepted, whenever the 4 existence of these isomers, esters, ethers and salts is 5 possible within the specific chemical designation: 6 "a. Acetylmethadol; 7 "b. Allylprodine; 8 "c. Alphacetylmethadol; 9 "d. Alphameprodine; 10 "e. Alphamethadol; 11 "f. Benzethidine; 12 "g. Betacetylmethadol; 13 "h. Betameprodine; 14 "i. Betamethadol; 15 "j. Betaprodine; 16 "k. Clonitazene; 17 "l. Dextromoramide; 18 "m. Dextrorphan; 19 "n. Diampromide; 20 "o. Diethylthiambutene; 21 "p. Dimenoxadol; 22 "q. Dimepheptanol; 23 "r.
    [Show full text]
  • Letter Bill 1..12
    Public Act 097-0193 HB2595 Enrolled LRB097 07359 RLC 47468 b AN ACT concerning criminal law. Be it enacted by the People of the State of Illinois, represented in the General Assembly: Section 5. The Illinois Controlled Substances Act is amended by changing Section 204 as follows: (720 ILCS 570/204) (from Ch. 56 1/2, par. 1204) Sec. 204. (a) The controlled substances listed in this Section are included in Schedule I. (b) Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of such isomers, esters, ethers and salts is possible within the specific chemical designation: (1) Acetylmethadol; (1.1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)- 4-piperidinyl]-N-phenylacetamide); (2) Allylprodine; (3) Alphacetylmethadol, except levo-alphacetylmethadol (also known as levo-alpha- acetylmethadol, levomethadyl acetate, or LAAM); (4) Alphameprodine; Public Act 097-0193 HB2595 Enrolled LRB097 07359 RLC 47468 b (5) Alphamethadol; (6) Alpha-methylfentanyl (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl) propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- propanilido) piperidine; (6.1) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl- 4-piperidinyl]-N-phenylpropanamide); (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP); (7.1) PEPAP (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine); (8) Benzethidine; (9) Betacetylmethadol; (9.1) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)- 4-piperidinyl]-N-phenylpropanamide);
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • 16.19.20 Nmac 1 Title 16 Occupational And
    TITLE 16 OCCUPATIONAL AND PROFESSIONAL LICENSING CHAPTER 19 PHARMACISTS PART 20 CONTROLLED SUBSTANCES 16.19.20.1 ISSUING AGENCY: Regulation and Licensing Department - Board of Pharmacy. [16.19.20.1 NMAC - Rp 16.19.20.1 NMAC, 06-26-2018] 16.19.20.2 SCOPE: All persons or entities that manufacture, distribute, dispense, administer, prescribe, deliver, analyze, or conduct research using controlled substances. [16.19.20.2 NMAC - Rp 16.19.20.2 NMAC, 06-26-2018] 16.19.20.3 STATUTORY AUTHORITY: Section 30-31-11 of the Controlled Substances Act, 30-31-1 through 30-31-42 NMSA 1978, authorizes the board of pharmacy to promulgate regulations and charge reasonable fees for the registration and control of the manufacture, distribution and dispensing of controlled substances. [16.19.20.3 NMAC - Rp 16.19.20.3 NMAC, 06-26-2018] 16.19.20.4 DURATION: Permanent. [16.19.20.4 NMAC - Rp 16.19.20.4 NMAC, 06-26-2018] 16.19.20.5 EFFECTIVE DATE: June 26, 2018, unless a different date is cited at the end of a section. [16.19.20.5 NMAC - Rp 16.19.20.5 NMAC, 06-26-2018] 16.19.20.6 OBJECTIVE: The objective of Part 20 of Chapter 19 is to protect the public health and welfare of the citizens of New Mexico by controlling and monitoring access to controlled substances and to give notice of the board’s designation of particular substances as controlled substances. [16.19.20.6 NMAC - Rp 16.19.20.6 NMAC, 06-26-2018] 16.19.20.7 DEFINITIONS: [RESERVED] [16.19.20.7 NMAC - Rp 16.19.20.7 NMAC, 06-26-2018] 16.19.20.8 REGISTRATION REQUIREMENTS: Persons required to register: A.
    [Show full text]